Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Andrew John Hugh Sims MacIntyre Insider Profile
4 Followers
Andrew John Hugh Sims MacIntyre, CFO at Plus Therapeutics, holds 9.81K shares in Plus Therapeutics (Ticker: PSTV). Most recently, Andrew John Hugh Sims MacIntyre Bought $4,098 shares of Plus Therapeutics on Sep 11, 2024 for an estimated value of 5.20K.
Andrew John Hugh Sims MacIntyre Plus Therapeutics (PSTV)CFO
Plus Therapeutics (PSTV)
CFO
Ranked #95,072 out of 99,335 Corporate Insiders
Profitable Transactions
0 out of 7 Profitable Transactions
Average Return
-58.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Andrew John Hugh Sims MacIntyre's holdings
Insider Roles
CFO
Roles that Andrew John Hugh Sims MacIntyre holds in companies
Most Profitable Insider Trade
The most profitable trade made by Andrew John Hugh Sims MacIntyre
Andrew John Hugh Sims MacIntyre's Trading History
List of latest transactions for each holding click on a transaction to see Andrew John Hugh Sims MacIntyre's performance on stock
You May Also Like
Andrew John Hugh Sims MacIntyre insider profile FAQ
What is the percentage of profitable transactions made by Andrew John Hugh Sims MacIntyre?
The percentage of profitable transactions made by Andrew John Hugh Sims MacIntyre is 0%.
What is the average return per transaction made by Andrew John Hugh Sims MacIntyre?
The average return per transaction made by Andrew John Hugh Sims MacIntyre is -58.00%.
What stocks does Andrew John Hugh Sims MacIntyre hold?
Andrew John Hugh Sims MacIntyre holds: PSTV stocks.
What was Andrew John Hugh Sims MacIntyre’s latest transaction?
Andrew John Hugh Sims MacIntyre latest transaction was an Informative Buy of $5.20K.
What was Andrew John Hugh Sims MacIntyre's most profitable transaction?
Andrew John Hugh Sims MacIntyre’s most profitable transaction was an Informative Buy of PSTV stock on September 11, 2024. The return on the trade was -8.80%.
What is Andrew John Hugh Sims MacIntyre's role in Plus Therapeutics?
Andrew John Hugh Sims MacIntyre's role in Plus Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.